Skip to main content
Eleftherios Mylonakis, MD, Infectious Disease, Houston, TX, Miriam Hospital

EleftheriosMylonakisMD

Infectious Disease • Houston, TX

Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School

Join to view full profile

Dr. Mylonakis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mylonakis' full profile

Already have an account?

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1999 - 2003
  • Brown University
    Brown UniversityResidency, Internal Medicine, 1995 - 1999
  • University of Athens
    University of AthensClass of 1990

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2023 - 2026
  • RI State Medical License
    RI State Medical License 2012 - 2024
  • MA State Medical License
    MA State Medical License 2002 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2011

Publications & Presentations

PubMed

Journal Articles

  • The Cost-Effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line-Associated Bloodstream Infections  
    Elina Eleftheria Pliakos, Nikolaos Andreatos, Eleftherios Mylonakis, Clinical Infectious Diseases
  • The Global Alliance for Infections in Surgery: Defining a Model for Antimicrobial Stewardship—Results from an International Cross-Sectional Survey  
    Richard R Watkins, Eleftherios Mylonakis, Robert G Sawyer, Costi D Sifri, BioMed Central

Press Mentions

  • FDA Committee OKs Modifying Boosters; Challenges Ahead for Manufacturers
    FDA Committee OKs Modifying Boosters; Challenges Ahead for ManufacturersJune 29th, 2022
  • Coronavirus Chronicles — Hitting Kids Hard
    Coronavirus Chronicles — Hitting Kids HardDecember 30th, 2021
  • Experimental Pill Could Be ‘Game Changer’ in Treating COVID-19, RI Doctors Say
    Experimental Pill Could Be ‘Game Changer’ in Treating COVID-19, RI Doctors SayNovember 5th, 2021
  • Join now to see all

Hospital Affiliations

Dr. Eleftherios Mylonakis, Dr. Eleftherios Mylonakis, MD, Dr. E Mylonakis